Diagnostic methods and kit for detecting cancer
AssigneeIndiana University Research and Technology Corporation
InventorHarikrishna NAKSHATRI
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed to compositions and methods for detecting elevated microRNA U6 concentrations in serum relative to a standard microRNA (e.g. SNORD44) as a diagnostic indicator of metastatic disease. In one embodiment the methods of the present disclosure are used to diagnose the existence of, or assess the risk of, breast cancer in an individual.
Claims10
An improved diagnostic screen for detecting and/or monitoring the progression of cancer, said method comprising
- isolating a serum sample from a subject;
- determining the concentration of a small microRNA, SNORD44 in said subject's sample;
- determining the concentration of a breast cancer-associated microRNA in said subject's sample;
- normalizing the concentration of said breast cancer-associated microRNA detected in said subject's sample and the concentrations of said breast cancer-associated microRNA present in samples from healthy individuals, using SNORD44 as a normalization control;
- and
- comparing the normalized concentrations wherein a difference in the normalized concentration of said breast cancer-associated microRNA in said subject's sample relative to healthy individual's samples indicates the presence of cancer.
A method of treating cancer, said method comprising the step of
- administering an inhibitor of RNAP-III in an amount effective to modulate the activity of RNAP-III to control cancer cell growth and/or the secondary effects of cancer.
A method of detecting cancer in a patient, said method comprising the steps of
- determining the concentration of microRNA U6 in a serum sample obtained form said patient;
- determining the concentration of microRNA SNORD44 in a serum sample obtained form said patient;
- inputting said determined concentration values into a computer comprising programming for analyzing the concentration of U6 relative to population data established for healthy individuals and using detected SNORD44 levels as a normalization control, wherein said programming produces a conclusion regarding the probability of the patient having cancer.
A kit for detecting and normalizing the presence of a breast cancer-associated microRNA, said kit comprising
- materials that can detect the presence of U6 microRNA;
- and
- materials that can detect the presence of SNORD44 microRNA.
Dependencies are inferred from the claim text.